(Q33782671)

English

Cystine-knot peptides engineered with specificities for α(IIb)β(3) or α(IIb)β(3) and α(v)β(3) integrins are potent inhibitors of platelet aggregation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Cystine-knot peptides engineered with specificities for α(IIb)β(3) or α(IIb)β(3) and α(v)β(3) integrins are potent inhibitors of platelet aggregation (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

molecular knots

1 reference

based on heuristic

inferred from title

platelet aggregation

1 reference

based on heuristic

inferred from title

author name string

Adam P Silverman

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Mihalis S Kariolis

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Jennifer R Cochran

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

publication date

1 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

Journal of Molecular Recognition

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

127-135

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Bleeding complications with the chimeric antibody to platelet glycoprotein IIb/IIIa integrin in patients undergoing percutaneous coronary intervention. EPIC Investigators

1 reference

https://api.crossref.org/works/10.1002%2FJMR.1036

21 January 2018

Designing repeat proteins: well-expressed, soluble and stable proteins from combinatorial libraries of consensus ankyrin repeat proteins.

1 reference

https://api.crossref.org/works/10.1002%2FJMR.1036

21 January 2018

Integrin alpha v beta 3 differentially regulates adhesive and phagocytic functions of the fibronectin receptor alpha 5 beta 1.

1 reference

https://api.crossref.org/works/10.1002%2FJMR.1036

21 January 2018

Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity

1 reference

https://api.crossref.org/works/10.1002%2FJMR.1036

21 January 2018

Agonist-specific structural rearrangements of integrin alpha IIbbeta 3. Confirmation of the bent conformation in platelets at rest and after activation

1 reference

https://api.crossref.org/works/10.1002%2FJMR.1036

21 January 2018

Design and synthesis of novel cyclic RGD-containing peptides as highly potent and selective integrin alpha IIb beta 3 antagonists

1 reference

https://api.crossref.org/works/10.1002%2FJMR.1036

21 January 2018

Effect of selective or combined inhibition of integrins alpha(IIb)beta(3) and alpha(v)beta(3) on thrombosis and neointima after oversized porcine coronary angioplasty

1 reference

https://api.crossref.org/works/10.1002%2FJMR.1036

21 January 2018

The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend

1 reference

https://api.crossref.org/works/10.1002%2FJMR.1036

21 January 2018

Multiple sequence alignment with hierarchical clustering

1 reference

https://api.crossref.org/works/10.1002%2FJMR.1036

21 January 2018

WebLogo: A Sequence Logo Generator

1 reference

https://api.crossref.org/works/10.1002%2FJMR.1036

21 January 2018

Integrin antagonists

1 reference

https://api.crossref.org/works/10.1002%2FJMR.1036

21 January 2018

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

https://api.crossref.org/works/10.1002%2FJMR.1036

21 January 2018

Engineered protein scaffolds as next-generation antibody therapeutics.

1 reference

https://api.crossref.org/works/10.1002%2FJMR.1036

21 January 2018

Engineered affinity proteins--generation and applications

1 reference

https://api.crossref.org/works/10.1002%2FJMR.1036

21 January 2018

Development and application of cytotoxic T lymphocyte-associated antigen 4 as a protein scaffold for the generation of novel binding ligands

1 reference

https://api.crossref.org/works/10.1002%2FJMR.1036

21 January 2018

Integrins: bidirectional, allosteric signaling machines

1 reference

https://api.crossref.org/works/10.1002%2FJMR.1036

21 January 2018

Design, pharmacology, and NMR structure of a minimized cystine knot with agouti-related protein activity

1 reference

https://api.crossref.org/works/10.1002%2FJMR.1036

21 January 2018

Evaluation of a (64)Cu-labeled cystine-knot peptide based on agouti-related protein for PET of tumors expressing alphavbeta3 integrin

1 reference

https://api.crossref.org/works/10.1002%2FJMR.1036

21 January 2018

Engineered knottin peptides: a new class of agents for imaging integrin expression in living subjects

1 reference

https://api.crossref.org/works/10.1002%2FJMR.1036

21 January 2018

Engineered cystine knot peptides that bind alphavbeta3, alphavbeta5, and alpha5beta1 integrins with low-nanomolar affinity

1 reference

https://api.crossref.org/works/10.1002%2FJMR.1036

21 January 2018

Alternative binding proteins: biological activity and therapeutic potential of cystine-knot miniproteins

1 reference

https://api.crossref.org/works/10.1002%2FJMR.1036

21 January 2018

Grafting of thrombopoietin-mimetic peptides into cystine knot miniproteins yields high-affinity thrombopoietin antagonists and agonists

1 reference

https://api.crossref.org/works/10.1002%2FJMR.1036

21 January 2018

Interrogating and predicting tolerated sequence diversity in protein folds: application to E. elaterium trypsin inhibitor-II cystine-knot miniprotein

1 reference

https://api.crossref.org/works/10.1002%2FJMR.1036

21 January 2018

Molecular recognition between serine proteases and new bioactive microproteins with a knotted structure

1 reference

https://api.crossref.org/works/10.1002%2FJMR.1036

21 January 2018

Use of phage display to probe the evolution of binding specificity and affinity in integrins

1 reference

https://api.crossref.org/works/10.1002%2FJMR.1036

21 January 2018

Targeting RGD recognizing integrins: drug development, biomaterial research, tumor imaging and targeting

1 reference

https://api.crossref.org/works/10.1002%2FJMR.1036

21 January 2018

Loops and links: structural insights into the remarkable function of the agouti-related protein

1 reference

https://api.crossref.org/works/10.1002%2FJMR.1036

21 January 2018

Pharmacophore refinement of gpIIb/IIIa antagonists based on comparative studies of antiadhesive cyclic and acyclic RGD peptides.

1 reference

https://api.crossref.org/works/10.1002%2FJMR.1036

21 January 2018

A decade of yeast surface display technology: where are we now?

1 reference

https://api.crossref.org/works/10.1002%2FJMR.1036

21 January 2018

Ligand binding to integrins

1 reference

https://api.crossref.org/works/10.1002%2FJMR.1036

21 January 2018

Engineered fibronectin type III domain with a RGDWXE sequence binds with enhanced affinity and specificity to human alphavbeta3 integrin

1 reference

https://api.crossref.org/works/10.1002%2FJMR.1036

21 January 2018

Development of eptifibatide

1 reference

https://api.crossref.org/works/10.1002%2FJMR.1036

21 January 2018

Multivalent avimer proteins evolved by exon shuffling of a family of human receptor domains

1 reference

https://api.crossref.org/works/10.1002%2FJMR.1036

21 January 2018

Engineered cystine-knot peptides that bind alpha(v)beta(3) integrin with antibody-like affinities

1 reference

https://api.crossref.org/works/10.1002%2FJMR.1036

21 January 2018

Alternative binding proteins: anticalins - harnessing the structural plasticity of the lipocalin ligand pocket to engineer novel binding activities

1 reference

https://api.crossref.org/works/10.1002%2FJMR.1036

21 January 2018

Multi-year follow-up of abciximab therapy in three randomized, placebo-controlled trials of percutaneous coronary revascularization

1 reference

https://api.crossref.org/works/10.1002%2FJMR.1036

21 January 2018

The potential of cystine-knot microproteins as novel pharmacophoric scaffolds in oral peptide drug delivery

1 reference

https://api.crossref.org/works/10.1002%2FJMR.1036

21 January 2018

Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics

1 reference

https://api.crossref.org/works/10.1002%2FJMR.1036

21 January 2018

Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand

1 reference

https://api.crossref.org/works/10.1002%2FJMR.1036

21 January 2018

Structure of a Complete Integrin Ectodomain in a Physiologic Resting State and Activation and Deactivation by Applied Forces

1 reference

https://api.crossref.org/works/10.1002%2FJMR.1036

21 January 2018

Identifiers

10.1002/JMR.1036

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33782671&oldid=1810810465"